15
https://pubmed.ncbi.nlm.nih.gov/38112201
A literature review shows heterogeneity and lack of reporting on important factors in studies examining the efficacy of PD-1/PD-L1 inhibitors in advanced or metastatic NSCLC patients with less common genetic alterations, indicating a need for further prospective studies.